TXG Stock Summary and Trading Ideas (10X Genomics | NASDAQ:TXG)

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10X Genomics trades on the NASDAQ stock market under the symbol TXG.

As of December 11, 2024, TXG stock price climbed to $16.32 with 325,952 million shares trading.

TXG has a beta of 1.41, meaning it tends to be more sensitive to market movements. TXG has a correlation of 0.09 to the broad based SPY ETF.

TXG has a market cap of $1.98 billion. This is considered a Small Cap stock.

Last quarter 10X Genomics reported $152 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-7 million and exceeded earnings estimates by $.04.

In the last 3 years, TXG traded as high as $154.10 and as low as $12.95.

The top ETF exchange traded funds that TXG belongs to (by Net Assets): ARKK, VTI, ARKG, VB, VXF.

TXG has underperformed the market in the last year with a return of -66.6%, while the SPY ETF gained +33.7%. In the last 3 month period, TXG fell short of the market, returning -24.7%, while SPY returned +11.2%. However, in the most recent 2 weeks TXG has outperformed the stock market by returning +8.7%, while SPY returned +1.3%.

TXG support price is $15.50 and resistance is $16.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TXG shares will trade within this expected range on the day.